Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Massachusetts General Hospital
University Hospital Bispebjerg and Frederiksberg
University of Miami
University of California, Irvine
Technische Universität Dresden
Massachusetts General Hospital
Duke University
Maastricht University Medical Center
Centre Hospitalier Universitaire de Saint Etienne
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
City of Hope Medical Center